AVNS - Avanos Medical: After Transformation Efforts, I Expect Inorganic Growth To Push The Price Up
2025-10-05 03:28:10 ET
Avanos Medical, Inc. ( AVNS ) looks undervalued considering that it is enhancing its international presence, reports an aggressive M&A strategy, and operates in growth target markets such as the neonatal enteral feeding devices market. AVNS recently elected a new CFO with expertise in M&A at Newell Brands and Equity Pacific Partners. Given the current state of the company's balance sheet, little debt, and the new CFO, I would expect inorganic growth in the near future. The result of my own DCF models indicated that AVNS appears substantially undervalued. A few years ago, AVNS traded at more than $59 per share. Right now, I am buying shares at close to $11 per share. From 2014 to 2025, the lowest price mark stands at $9.30 per share. ...
Avanos Medical: After Transformation Efforts, I Expect Inorganic Growth To Push The Price Up